Abbreviations ASCVD: Atherosclerotic cardiovascular disease BMI: Body mass index CI: Confidence interval CKD: Chronic kidney disease CVD: Cardiovascular disease eGFR: Estimated glomerular filtration ratio GLP-1RA: Glucagon-like peptide-1 receptor agonist HFpEF: Heart failure with preserved ejection fraction HFrEF: Heart failure with reduced ejection fraction HHF: Heart failure hospitalization HR: Hazard ratio LDL: Low-density lipoprotein LVEF: Left ventricular ejection fraction MACE: Major cardiovascular events MRA: Mineralocorticoid receptor antagonist SGLT2: Sodium-glucose cotransporter 2 References Wong ND, Sattar N
Sulforaphane: a review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials
Badenhorst et al., Journal of Cosmetic Dermatology, 2016 GHK-Cu Before and After: The Week-by-Week Timeline The most important thing to understand about GHK-Cu results is that they are cumulative and progressive
M.WeaverJ
It is designed to reveal and enhance the underlying musculature by selectively removing stubborn fat around areas such as the abdomen, chest, flanks, arms, and waist
MyD88, myeloid differentiation factor 88